COPD
From the Journals
Quitting tobacco can improve lung health in COPD
A knowledge summary from the World Health Organization also emphasizes the need for control measures to protect youth from tobacco marketing.
Supplements
Pulmonology Data Trends 2023 (PDF)
From the Journals
In-hospital mortality increased in COPD patients with acute exacerbations and high serum phosphate levels
Acute exacerbations of chronic obstructive pulmonary disease linked to higher in-hospital mortality among AECOPD patients with high serum...
Pulmonary Perspectives®
Home oxygen therapy: What does the data show?
Chronic obstructive pulmonary disease is the most common reason for the prescription of long-term oxygen therapy.
Conference Coverage
Short, long-lasting bronchodilators similar for exacerbated COPD
Long-lasting bronchodilators are recommended by the Gold Report, but clinical evidence was lacking in this population.
Article
Updated Guidelines for COPD Management: 2023 GOLD Strategy Report
News from the FDA/CDC
FDA warns AstraZeneca over ‘misleading claims’ about COPD drug
The FDA issued the warning letter on Aug. 4 and published it on Aug. 15.
Latest News
Generic inhalers for COPD support hold their own
“I don’t see a clinical reason why one would ever need to get the brand name over the generic version.”
From the Journals
COPD plus PRISm may promote frailty progression
Frailty progression was significantly accelerated in patients with PRISm and COPD.
From the Journals
Classification of COPD exacerbation predicts prognosis
Patients hospitalized with severe exacerbations of ECOPD are at increased risk for worse clinical outcomes and death.